Ischemic stroke - novel therapeutic strategies

Acta Neurologica Scandinavica

Volumn 124, Issue SUPPL. 191, 2011, Pages 28-37

  Farbu, E ^a   Kurz, K D ^a   Kurz, M W ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ischemic stroke; IVT; Stroke units; Thrombectomy

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOPLASTY; ARTICLE; BASILAR ARTERY; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DECOMPRESSION SURGERY; DIAGNOSTIC IMAGING; FIBRINOLYTIC THERAPY; HUMAN; INTERNAL CAROTID ARTERY; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECANALIZATION; REPERFUSION; STENT; STROKE PATIENT; STROKE UNIT; METHODOLOGY; REVIEW; STROKE; THROMBECTOMY; TIME; TREATMENT OUTCOME;

BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 80955141892     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01540.x     Document Type: Article

References (47)

1. Bonita R, Solomon N, Broad JB. Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies. Stroke 1997;28:1898-902.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
3. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;4:CD000197.
4. Prasad K, Mendelow AD, Gregson B. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev 2008;4:CD000200.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
6. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
7. Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry 2005;76:1238-41.
8. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, Del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13.
9. Wechsler LR. Imaging evaluation of acute ischemic stroke. Stroke 2011;42(1 Suppl):S12-5.
10. Indredavik B. [What characterises an effective stroke unit?]. Tidsskr Nor Laegeforen 2007;127:1214-8.
11. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
12. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
13. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000;31:811-6.
14. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-26.
15. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
16. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009;4:CD000213.
17. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73.
18. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54.
19. Del Zoppo GJ, Ferbert A, Otis S et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke 1988;19:307-13.
20. Gonner F, Remonda L, Mattle H et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894-900.
21. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-22.
22. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
23. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
24. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA. Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009;30:859-75.
25. Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-9.
26. Saver JL. Intra-arterial fibrinolysis for acute ischemic stroke: the message of melt. Stroke 2007;38:2627-8.
27. Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33:2866-71.
28. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37:922-8.
29. Schonewille WJ, Wijman CA, Michel P et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009;8:724-30.
30. Lewandowski CA, Frankel M, Tomsick TA et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605.
31. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004;35:904-11.
32. IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:2127-35.
33. Khatri P, Hill MD, Palesch YY et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130-7.
34. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8.
35. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82.
36. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274-80.
37. Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13.
38. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
39. Tarr RW, Hsu D, Alfke K et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J NeuroIntervent Surg 2010;2:341-4.
40. Kulcsar Z, Bonvin C, Pereira VM et al. Penumbra system: a novel mechanical thrombectomy device for large-vessel occlusions in acute stroke. AJNR Am J Neuroradiol 2010;31:628-33.
41. Mpotsaris A, Bussmeyer M, Loehr C, Oelerich M, Buchner H, Weber W. Mechanical thrombectomy in severe acute stroke: preliminary results of the Solitaire stent. J Neurol Neurosurg Psychiatry 2011 Jan 6. Epub ahead of print.
42. Brekenfeld C, Schroth G, Mattle HP et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009;40:847-52.
43. Levy EI, Mehta R, Gupta R et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816-22.
44. Levy EI, Siddiqui AH, Crumlish A et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-6.
45. Merenda A, DeGeorgia M. Craniectomy for acute ischemic stroke: how to apply the data to the bedside. Curr Opin Neurol 2010;23:53-8.
46. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
47. Baker WL, Colby JA, Tongbram V et al. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med 2011;154:243-52.